NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 327 filers reported holding NOVOCURE LTD in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $234,353 | -41.5% | 14,511 | +117.8% | 0.03% | -16.7% |
| Q1 2023 | $400,773 | -69.0% | 6,664 | -57.3% | 0.04% | -66.7% |
| Q1 2022 | $1,294,000 | -0.6% | 15,613 | -10.0% | 0.11% | -6.1% |
| Q4 2021 | $1,302,000 | -17.4% | 17,347 | +27.9% | 0.12% | -39.2% |
| Q3 2021 | $1,576,000 | +384.9% | 13,563 | +451.8% | 0.19% | +166.2% |
| Q1 2021 | $325,000 | -18.8% | 2,458 | +6.4% | 0.07% | -43.7% |
| Q4 2020 | $400,000 | – | 2,310 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |